Cargando…
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?
Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326129/ https://www.ncbi.nlm.nih.gov/pubmed/34345206 http://dx.doi.org/10.7150/ijbs.63969 |
| _version_ | 1783731708535767040 |
|---|---|
| author | Santamaria, Salvatore |
| author_facet | Santamaria, Salvatore |
| author_sort | Santamaria, Salvatore |
| collection | PubMed |
| description | Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al. |
| format | Online Article Text |
| id | pubmed-8326129 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Ivyspring International Publisher |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83261292021-08-02 Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? Santamaria, Salvatore Int J Biol Sci Commentary Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al. Ivyspring International Publisher 2021-07-05 /pmc/articles/PMC8326129/ /pubmed/34345206 http://dx.doi.org/10.7150/ijbs.63969 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
| spellingShingle | Commentary Santamaria, Salvatore Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
| title | Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
| title_full | Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
| title_fullStr | Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
| title_full_unstemmed | Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
| title_short | Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
| title_sort | targeting the pi3k/akt pathway: a potential new weapon in the global fight against sars-cov-2? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326129/ https://www.ncbi.nlm.nih.gov/pubmed/34345206 http://dx.doi.org/10.7150/ijbs.63969 |
| work_keys_str_mv | AT santamariasalvatore targetingthepi3kaktpathwayapotentialnewweaponintheglobalfightagainstsarscov2 |